QUOTE AND NEWS
TheStreet.com  Apr 16  Comment 
NEW YORK (TheStreet) -- Shares of Pernix Therapeutics  plunged 17.95% to $8.18 in afternoon trading Thursday after the company updated its full-year 2015 guidance. The company now expects net sales for the three months ended March 31, 2015,...
TheStreet.com  Feb 10  Comment 
NEW YORK (TheStreet) -- Shares of Pernix Therapeutics Holdings are up 6.49% to $8.70 in morning trading on Tuesday after Cantor Fitzgerald initiated the company with a "buy" rating and a $11 price target.   "Pernix is a speciality pharma...
Benzinga  Dec 30  Comment 
Analysts at JMP Securities initiated coverage on shares of Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) with a Market Outperform rating. The target price for Pernix Therapeutics is set to $13. Pernix Therapeutics shares have gained...
StreetInsider.com  Nov 11  Comment 
Cyanotech Corp (Nasdaq: CYAN) 21.9% HIGHER; reported Q2 EPS of $0.03, versus $0.02 reported last year. Revenue for the quarter came in at $8.68 million, versus $7.3 million reported last year. Vivint Solar (NYSE: VSLR) 21.6% LOWER; reported Q3...
StreetInsider.com  Aug 20  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/TREXIMET+Rights+Acquired+by+Pernix+Therapeutics+%28PTX%29+%28POZN%29+%28GSK%29/9769580.html for the full story.
SeekingAlpha  Aug 11  Comment 
Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) Q2 2014 Results Conference Call August 11, 2014; 10:00 a.m. ET Executives Doug Drysdale - Chairman, President & Chief Executive Officer Sanjay Patel - Chief Financial Officer Tracy...
StreetInsider.com  Aug 4  Comment 
* Pike Corporation (NYSE: PIKE) announced today that it has signed a definitive merger agreement under which investment firm Court Square Capital Partners in partnership with J. Eric Pike, the Company's Chairman and Chief Executive Officer, will...
StreetInsider.com  Jun 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Pernix+Therapeutics+%28PTX%29+Names+New+CFO/9604950.html for the full story.





 



References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki